Abstract: A method includes a computer receiving a fulfillment request associated with one or more items. Responsive to receiving the fulfillment request, the computer determines estimated weight data based on the one or more items in the fulfillment request. The computer obtains actual weight data associated with the fulfillment request for one or more items. The computer verifies that the actual weight data corresponds to the estimated weight data. The computer performs additional processing based on verifying.

Abstract: Systems and methods for monitoring computer and/or software usage and enhancing functionality of target software applications are provided. In some aspects, the systems and methods may identify user activity with sufficient depth for meaningful analysis, even when the target application restricts access to, for example, its user-interface object model or event stream, without requiring code-level integration with the target application. In other aspects, the systems and methods may enable fast and convenient assignment of semantic meaning to user-interface elements to enable actionable usage reporting, among other things In further aspects, the systems and methods may allow convenient definition of a sequence of user-interface actions as a workflow, which may be analyzed in a variety of manners including, for example, monitoring and analyzing for user utilization and compliance.

Abstract: The method of the invention is based on a membership-only association (“MOA”). Preferably, the MOA operates as a not-for-profit entity having a formal organization such as a corporation or LLC. MOA receives membership fees to pay for accounting fees, legal fees, product liability insurance, and year-end buy backs of dead back-up inventory. The MOA solicits retailers, designers, wholesalers, and manufacturers, or some combination thereof, to become members of the association. Applicants for membership are screened based on criteria determined by founding members of the MOA. Once accepted, the prospective member enters into a contractual relationship with the MOA. The types of members include, by way of example, Design Members, Supply Members, Logistical Wholesale Members, and Retail Members. Administration, logistics, and communications among the Design, Retail, and Logistical Wholesale Members are facilitated by a Support Entity.

Abstract: The method of the invention is based on a membership-only association (“MOA”). Preferably, the MOA operates as a not-for-profit entity having a formal organization such as a corporation or LLC. MOA receives membership fees to pay for accounting fees, legal fees, product liability insurance, and year-end buy backs of dead back-up inventory The MOA solicits retailers, designers, wholesalers, and manufacturers, or some combination thereof, to become members of the association Applicants for membership are screened based on criteria determined by founding members of the MOA. Once accepted, the prospective member enters into a contractual relationship with the MOA The types of members include, by way of example, Design Members, Supply Members, Logistical Wholesale Members, and Retail Members. Administration, logistics, and communications among the Design, Retail, and Logistical Wholesale Members are facilitated by a Support Entity.

Abstract: The present invention relates to novel nodulosporic acid derivatives, which are acaricidal, antiparasitic, insecticidal and anthelmintic agents.

Abstract: The present invention relates to novel nodulosporic acid derivatives, which are acaricidal, antiparasitic, insecticidal and anthelmintic agents.

Abstract: The present invention relates to novel nodulosporic acid derivatives, which are acaricidal, antiparasitic, insecticidal and anthelmintic agents.

Abstract: Substituted sulfonamides are selective .beta..sub.3 adrenergic receptor agonists with very little .beta..sub.1 and .beta..sub.2 adrenergic receptor activity and as such the compounds are capable of increasing lipolysis and energy expenditure in cells. The compounds thus have potent activity in the treatment of Type II diabetes and obesity. The compounds can also be used to lower triglyceride levels and cholesterol levels or raise high density lipoprotein levels or to decrease gut motility. In addition, the compounds can be used to reduced neurogenic inflammation or as antidepressant agents. The compounds are prepared by coupling an aminoalkylphenyl-sulfonamide with an appropriately substituted epoxide. Compositions and methods for the use of the compounds in the treatment of diabetes and obesity and for lowering triglyceride levels and cholesterol levels or raising high density lipoprotein levels or for increasing gut motility are also disclosed.

Abstract: A continuous process for the preparation of polyoxyalkylene polyethers using DMC catalysts as the polyoxyalkylation catalyst employs continuous addition of alkylene oxide in conjunction with continuous addition of starter and catalyst to a continuous oxyalkylation reactor. Despite the continuous introduction of starter, the molecular weight distribution of the polyether product is quite narrow, as indicated by the exceptionally low polydispersity of the product. The presence of low molecular weight species during the majority of the polyoxyalkylation also substantially eliminates extremely high molecular weight fractions having molecular weights greater than 100,000 Da, again without appreciably broadening molecular weight distribution. By withdrawing intermediate molecular weight polyether product or diverting a portion of the end product to prepare a catalyst/starter mixture, rapid and sustained reaction rates can be achieved while employing low molecular weight starters.

Abstract: Substituted sulfonamides are selective .beta..sub.3 adrenergic receptor agonists with very little .beta..sub.1 and .beta..sub.2 adrenergic receptor activity and as such the compounds are capable of increasing lipolysis and energy expenditure in cells. The compounds thus have potent activity in the treatment of Type II diabetes and obesity. The compounds can also be used to lower triglyceride levels and cholesterol levels or raise high density lipoprotein levels or to decrease gut motility. In addition, the compounds can be used to reduced neurogenic inflammation or as antidepressant agents. The compounds are prepared by coupling an aminoalkylphenyl-sulfonamide with an appropriately substituted epoxide. Compositions and methods for the use of the compounds in the treatment of diabetes and obesity and for lowering triglyceride levels and cholesterol levels or raising high density lipoprotein levels or for increasing gut motility are also disclosed.

Abstract: The method for the separating close-boiling impurities from propylene oxide essentially free of high molecular weight poly (propylene oxide) which comprises contacting the impure propylene oxide with solid activated carbon adsorbent and separating propylene oxide reduced in impurities content from the adsorbent.

Abstract: A method of recovering optically active epoxy alcohols from asymmetric epoxidation reaction mixture is provided whereby the epoxy alcohol may be obtained in high yield with minimal degradation of optical purity. The process is also suitable for the synthesis of useful organic sulfonate derivatives of chiral epoxy alcohols.

Abstract: The method for the separating close-boiling impurities from C.sub.2 -C.sub.4 l alkylene oxide which comprises contacting the impure alkylene oxide with solid activated carbon adsorbent and separating alkylene oxide reduced in impurities content from the adsorbent.

Abstract: The present invention provides an improved process for the separation of impurities from a lower alkylene oxide, such as propylene oxide, by a process wherein the impure propylene oxide is first fractionally distilled to separate higher and lower boiling impurities, then the partially purified alkylene oxide is subjected to extractive distillation to separate additional impurities, the purified propylene oxide being separated as an overhead fraction.

Abstract: A method is provided for the separation by extractive distillation of hydrocarbon impurities from lower alkylene oxides such as propylene oxide wherein a glycol having 2 to 5 carbon atoms is used as extractive solvent.

Abstract: The method for the separating methyl formate from lower alkylene oxide such as propylene oxide which comprises contacting the impure alkylene oxide with basic ion exchange resin and separating alkylene oxide reduced in methyl formate content.

Abstract: A method is provided for the separation by extractive distillation of hydrocarbon impurities from propylene oxide wherein t-butyl alcohol/water is used as extractive distillation solvent.

Abstract: A method is provided for the separation by extractive distillation of oxygenated impurities from a monoepoxide while avoiding epoxide loss, wherein lower glycol is used as extractive solvent in amounts so as to provide only up to about 0.3 mol % solvent in the vapor in the extractive distillation zone.

Abstract: Purification of tetrahydrofuran from the dehydrocyclization of 1,4-butanediol in the presence of an organic acid catalyst has been accomplished by the extractive distillation of crude tetrahydrofuran containing water using monopropylene glycol as an extractive solvent.